CHGA and Alzheimer disease: When applied to our murine model, BoNE revealed that male Chromogranin A–deficient PS19 mice (CgA-KO/PS19) exhibit robust AD-like transcriptomic signatures in the hippocampus and entorhinal cortex yet retain intact cognitive function—recapitulating the clinicopathologic dissociation observed in human AsymAD.